---
title: "12-Panel PCP, MDMA & Buprenorphine Compact Drug Test Cup – 90 mL | AMP, BAR, BUP, BZO, COC, MDMA, MET, MTD, OPI, OXY, PCP & THC"
url: "https://rapidscreening.surgescientific.com/products/12-panel-drug-test-cup-90ml-clia-waived-fda-approved-urine-test-cup-as-low-as-1-29"
description: ".surge-12pcp90-product { max-width: 1100px; margin: 0 auto; padding: 0; font-family: Arial, Helvetica, sans-serif; color: #0F2742; line-height: 1.5; } ."
---

# 12-Panel PCP, MDMA & Buprenorphine Compact Drug Test Cup – 90 mL | AMP, BAR, BUP, BZO, COC, MDMA, MET, MTD, OPI, OXY, PCP & THC

.surge-12pcp90-product { max-width: 1100px; margin: 0 auto; padding: 0; font-family: Arial, Helvetica, sans-serif; color: #0F2742; line-height: 1.5; } .surge-12pcp90-product * { box-sizing: border-box; } .surge-12pcp90-product h2, .surge-12pcp90-product h3, .surge-12pcp90-product p { padding: 0 !important; } .surge-12pcp90-product h2 { margin: 0 0 9px !important; line-height: 1.2; } .surge-12pcp90-product h3 { margin: 22px 0 9px !important; line-height: 1.25; } .surge-12pcp90-product p { margin: 0 0 9px !important; } .surge-12pcp90-feature-grid { display: grid; grid-template-columns: repeat(4, minmax(0, 1fr)); gap: 10px; margin: 14px 0 18px; } .surge-12pcp90-feature { background: #F4FAFA; border-top: 4px solid #0A7373; border-radius: 8px; padding: 14px; } .surge-12pcp90-feature strong { display: block; color: #0A7373; font-size: 16px; line-height: 1.3; margin-bottom: 4px; } .surge-12pcp90-banner { background: #0F2742; color: #FFFFFF; border-radius: 9px; padding: 19px; margin: 17px 0; } .surge-12pcp90-banner strong { display: block; font-size: 21px; line-height: 1.3; margin-bottom: 4px; } .surge-12pcp90-table-wrap { width: 100%; overflow-x: auto; margin: 10px 0 13px; } .surge-12pcp90-drug-table, .surge-12pcp90-spec-table { width: 100%; border-collapse: collapse; margin: 0; } .surge-12pcp90-drug-table { min-width: 760px; border: 2px solid #0A7373; } .surge-12pcp90-drug-table th { background: #0A7373; color: #FFFFFF; padding: 12px 10px; text-align: left; font-size: 14px; border-right: 1px solid #FFFFFF; } .surge-12pcp90-drug-table th:first-child { text-align: center; } .surge-12pcp90-drug-table td { padding: 10px 12px; vertical-align: middle; border-bottom: 1px solid #D7E7E7; } .surge-12pcp90-drug-table tr:nth-child(even), .surge-12pcp90-spec-table tr:nth-child(even) { background: #F4FAFA; } .surge-12pcp90-strip { display: inline-block; min-width: 145px; padding: 5px 8px; color: #FFFFFF; text-align: center; font-size: 8px; font-weight: bold; line-height: 1.25; } .surge-12pcp90-note { background: #FFF7EF; border-left: 5px solid #BF6000; padding: 14px 16px; margin: 13px 0 18px; } .surge-12pcp90-note strong { color: #BF6000; } .surge-12pcp90-info { background: #EAF7F6; border: 1px solid #BFDCD9; border-left: 5px solid #0A7373; padding: 14px 16px; margin: 13px 0 18px; } .surge-12pcp90-info strong { display: block; color: #0A7373; font-size: 18px; margin-bottom: 4px; } .surge-12pcp90-result { padding: 14px 16px; border: 1px solid #D7E7E7; margin: 0; } .surge-12pcp90-result:first-child { border-radius: 8px 8px 0 0; } .surge-12pcp90-result:last-child { border-radius: 0 0 8px 8px; } .surge-12pcp90-result strong { display: block; font-size: 18px; margin-bottom: 3px; } .surge-12pcp90-spec-table { min-width: 520px; border: 1px solid #D7E7E7; } .surge-12pcp90-spec-table td { padding: 10px 12px; border-bottom: 1px solid #D7E7E7; } .surge-12pcp90-regulatory { display: grid; grid-template-columns: 1fr 1fr; gap: 10px; margin: 13px 0 18px; } .surge-12pcp90-regulatory-box { background: #F4FAFA; border-left: 5px solid #0A7373; padding: 15px; border-radius: 7px; } .surge-12pcp90-regulatory-box strong { display: block; color: #0A7373; font-size: 18px; margin-bottom: 4px; } .surge-12pcp90-faq { border: 1px solid #D7E7E7; border-radius: 8px; overflow: hidden; margin: 12px 0 18px; } .surge-12pcp90-faq-item { padding: 15px 16px; border-bottom: 1px solid #D7E7E7; } .surge-12pcp90-faq-item:last-child { border-bottom: 0; } .surge-12pcp90-faq-item:nth-child(even) { background: #F4FAFA; } .surge-12pcp90-faq-item strong { display: block; color: #0A7373; font-size: 17px; margin-bottom: 4px; } .surge-12pcp90-cta { background: linear-gradient(135deg, #0F2742 0%, #0A7373 100%); color: #FFFFFF; text-align: center; border-radius: 10px; padding: 24px 20px; margin: 20px 0 13px; } .surge-12pcp90-cta strong { display: block; font-size: 24px; line-height: 1.3; margin-bottom: 7px; } .surge-12pcp90-cta-button { display: inline-block; background: #BF6000; color: #FFFFFF; padding: 10px 23px; border-radius: 5px; font-weight: bold; margin-top: 12px; } @media screen and (max-width: 850px) { .surge-12pcp90-feature-grid { grid-template-columns: 1fr 1fr; } } @media screen and (max-width: 600px) { .surge-12pcp90-feature-grid, .surge-12pcp90-regulatory { grid-template-columns: 1fr; } .surge-12pcp90-product h2 { font-size: 27px !important; } .surge-12pcp90-product h3 { font-size: 22px !important; } } 12 DRUG PANELS • PCP, MDMA &amp; BUP • COMPACT 90 mL 12-Panel PCP, MDMA &amp; Buprenorphine Compact Drug Test Cup Comprehensive preliminary urine drug screening in a compact, space-saving 90 mL cup. This self-contained test cup screens for amphetamines, barbiturates, buprenorphine, benzodiazepines, cocaine, MDMA, methamphetamine, methadone, opiates, oxycodone, phencyclidine and marijuana. Dedicated PCP, MDMA, BUP, MTD, OPI and OXY panels provide broad screening across stimulants, sedatives, opioids, hallucinogens and marijuana. The compact design supports easy handling and storage while delivering preliminary results in approximately five minutes. Product Highlights Twelve-Drug Screening Screens for AMP/ 1000, OPI/ 300, MET /1000, BZO/ 300, COC/ 300, MTD /300, OXY/ 100, BUP /10, MDMA/ 500, THC/50, BAR/300, PCP /25 Dedicated PCP Panel Screens for phencyclidine at the manufacturer-listed 25 ng/mL cutoff. Dedicated MDMA Panel Screens for MDMA or ecstasy at the listed 500 ng/mL cutoff. Buprenorphine Screening Includes a separate BUP panel at the listed 10 ng/mL cutoff. Expanded Opioid Coverage Includes dedicated BUP, MTD, OPI and OXY screening panels. Results in 5 Minutes Provides clear preliminary results for efficient onsite screening. Compact 90 mL Capacity Provides sufficient specimen capacity in an easy-to-store format. One-Step Testing Collection and preliminary screening are completed using one device. Leak-Resistant Lid Secure closure helps reduce spills, leakage and accidental opening. Built-In Temperature Strip Supports prompt verification that specimen temperature is within the expected range. Single-Use Format Designed for hygienic, one-time specimen collection and preliminary screening. Manufacturer-Stated Accuracy Manufacturer information reports up to 99% accuracy when used as directed. Twelve Drug Panels with PCP, MDMA and Buprenorphine Screening A compact option for healthcare facilities, rehabilitation programs, occupational health clinics, collection sites, correctional settings and authorized workplace screening. Drug Panels and Cutoff Levels Review the twelve drug categories and manufacturer-listed preliminary screening cutoff levels. TEST STRIP TESTED DRUG ESTIMATED DETECTION TIME / CUTOFF AMP AMP AMP AMP AMP AMP AMP AMP AMP AMP Amphetamines 1–2 Days • 1,000 ng/mL BAR BAR BAR BAR BAR BAR BAR BAR BAR BAR Barbiturates 1–4 Days • 300 ng/mL BUP BUP BUP BUP BUP BUP BUP BUP BUP BUP Buprenorphine 2–6 Days • 10 ng/mL BZO BZO BZO BZO BZO BZO BZO BZO BZO BZO Benzodiazepines 1–2 Days • 300 ng/mL COC COC COC COC COC COC COC COC COC COC Cocaine 2–4 Days • 300 ng/mL MDMA MDMA MDMA MDMA MDMA MDMA MDMA MDMA MDMA / Ecstasy 2–4 Days • 500 ng/mL MET MET MET MET MET MET MET MET MET MET Methamphetamine 2–4 Days • 1,000 ng/mL MTD MTD MTD MTD MTD MTD MTD MTD MTD MTD Methadone 1–3 Days • 300 ng/mL OPI OPI OPI OPI OPI OPI OPI OPI OPI OPI Morphine / Opiates 2–3 Days • 300 ng/mL OXY OXY OXY OXY OXY OXY OXY OXY OXY OXY Oxycodone 1–3 Days • 100 ng/mL PCP PCP PCP PCP PCP PCP PCP PCP PCP PCP Phencyclidine 7–14 Days • 25 ng/mL THC THC THC THC THC THC THC THC THC THC Marijuana 5+ Days • 50 ng/mL Please Note: Detection windows vary according to dosage, frequency of use, metabolism, hydration, body composition, specimen concentration and other individual factors.Refer to the manufacturer’s package insert for exact cutoff levels, cross-reactivity information and interpretation instructions. Dedicated PCP Screening The PCP panel provides preliminary screening for phencyclidine at the manufacturer-listed 25 ng/mL cutoff. It does not measure concentration or indicate the timing or degree of exposure. Separate BUP, MTD, OPI and OXY Panels Buprenorphine, methadone and oxycodone may not be detected with equal sensitivity by a traditional opiate panel. Dedicated strips provide targeted preliminary screening for each listed analyte. Compact Without Sacrificing Coverage The 90 mL format combines specimen collection, temperature verification and twelve-panel screening while requiring less storage space than a standard 120 mL cup. How to Use the 12-Panel PCP, MDMA &amp; Buprenorphine Compact Drug Test Cup Understanding the 12-Panel PCP, MDMA &amp; Buprenorphine Compact Drug Test Cup Results Product Dimensions and Specifications 12-Panel PCP, MDMA &amp; Buprenorphine Compact Drug Test Cup Drug panels AMP, BAR, BUP, BZO, COC, MDMA, MET, MTD, OPI, OXY, PCP and THC Buprenorphine cutoff BUP/10 MDMA cutoff MDMA/500 Opiate cutoff OPI/300 Oxycodone cutoff OXY/100 PCP cutoff PCP/25 Result time Approximately 5 minutes Capacity 90 mL Height 6.5 cm Width 5.4 cm Lid width 7 cm Approximate weight 0.18 lb Use Single-use urine collection and preliminary screening device CLIA Waived and FDA 510(k) Cleared According to the supplied manufacturer information, this exact 12-panel configuration is CLIA Waived and FDA 510(k) Cleared for the intended uses identified in its labeling. Confirm the regulatory status printed on the exact product packaging before advertising or use. What CLIA Waived Means Eligible point-of-care sites may use the test under a CLIA Certificate of Waiver when the manufacturer’s instructions and applicable federal, state and local requirements are followed. What FDA 510(k) Cleared Means The device completed the applicable FDA premarket-clearance process and was found substantially equivalent to a legally marketed predicate for its labeled intended use. Depending on its exact labeling and applicable requirements, this cup may be suitable for physician offices, healthcare facilities, occupational health clinics, treatment and rehabilitation programs, drug-testing collection sites, probation and correctional programs and qualifying workplace-screening programs. Regulatory Notice: FDA clearance and CLIA-waived status are separate designations. Regulatory status may vary by exact cup configuration or individual assay, and state or local requirements may apply. Frequently Asked Questions 1. Which substances does this 12-panel cup screen for? It screens for amphetamines, barbiturates, buprenorphine, benzodiazepines, cocaine, MDMA, methamphetamine, methadone, opiates, oxycodone, phencyclidine and marijuana. 2. Does this cup include a separate PCP panel? Yes. It includes dedicated phencyclidine screening at the manufacturer-listed cutoff of 25 ng/mL. 3. Why are BUP, MTD, OPI and OXY tested separately? Buprenorphine, methadone and oxycodone may not be detected with equal sensitivity by a traditional opiate panel. Separate strips provide targeted preliminary screening. 4. Does the smaller 90 mL format affect the panel coverage? No. The compact cup still provides sufficient specimen capacity for the integrated twelve-panel screening process when used according to the package insert. 5. Does the temperature strip prove specimen authenticity? No. It measures specimen temperature shortly after collection and helps identify samples outside the expected range. It does not independently prove authenticity or detect every form of tampering. 6. Is a presumptive positive result final? No. Presumptive positive results should be confirmed using an appropriate laboratory method before clinical, employment, legal or treatment decisions are made. Twelve Drug Panels. PCP, MDMA and Buprenorphine Screening. Compact 90 mL Design. Simplify preliminary urine drug screening with a compact, self-contained cup designed for broad panel coverage, secure collection and easy visual interpretation. Order 12-Panel Compact Test Cups Today

## Offer

- Price: $2.70

- Availability: In stock

## Collection

- [12 Panel](https://rapidscreening.surgescientific.com/collections/12-panel.md)

## Links

- [HTML product page](https://rapidscreening.surgescientific.com/products/12-panel-drug-test-cup-90ml-clia-waived-fda-approved-urine-test-cup-as-low-as-1-29)
- [All collections](https://rapidscreening.surgescientific.com/collections.md)
